Lewis Asset Management’s Avalyn Pharma AVLN Stock Holding History
Bought
Maintained
Sold
Other funds holding AVLN
Lewis Asset Management's AVLN Position: Q3 2026 in Review
Lewis Asset Management opened a new position in Avalyn Pharma (AVLN) in Q3 2026: 8,000 shares worth $228K. The stake represents 0.08% of the portfolio and ranks #200 among its holdings.
116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.
- Lewis Asset Management held 8,000 shares of Avalyn Pharma worth $228K as of Q3 2026.
- Avalyn Pharma was a new Lewis Asset Management position in Q3 2026.
- Avalyn Pharma made up 0.08% of Lewis Asset Management's portfolio in Q3 2026, its #200 holding.
- 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.
Based on Lewis Asset Management's 13F filing for Q3 2026, filed 14 Oct 2026.